Role of Rasayan Churna in outbreak of Covid -19 as preventive and curative aspect

Amol Madhav Deshpande (1) , Mayuri Amol Deshpande (2)
(1) Department of Rachana Sharir, Mahatma Gandhi Ayurved College, Hospital & Research Centre, DMIMS (DU), Salod (H), Wardha, Maharashtra, India, India ,
(2) Department of Kayachikitsa, Mahatma Gandhi Ayurved College, Hospital & Research Centre, DMIMS (DU) Salod (H), Wardha, Maharashtra, India, India

Abstract

In last two decade world suffer with three epidemic diseases like SARS-CoV, H1N1 influenza, MERS –CoV and presently the world under a pandemic of Covid-19, out of these SARS-CoV, MERS –CoV and Covid-19 are form the same virus call as corona, which primary present on bats and transferred from animal to human, and then it transfer from human to human mostly by respiratory droplets or in the direct contact with the diseased person, these recurrent infection of corona virus is the burning issue in the word, so to avoid these recurrent infections good habitual behaviour with regular immune booster medicine should be taken which can be used in both normal and symptomatic patient for this Rasayan churna  is the best drug of choice as it is used for  rejuvenation therapy. From literally study from various recourses it is found that Rasayan churna have property anti-depressant, anti-xylotic, Immunomodulatory, Anti-diabetes, anti hypertensive, anti-inflammatory, Anti-toxic effects, Anti-arthritic, Anti-cancer effects, Anti-microbial effect, and Anti-oxidant which can be useful in preventive aspect of Covid -19 in all phase like normal individual, also can be used in asymptomatic patients and symptomatic patients, clinical study can be performed for the same to evaluate the result.

Full text article

Generated from XML file

Authors

Amol Madhav Deshpande
deshpandeamol86@gmail.com (Primary Contact)
Mayuri Amol Deshpande
Amol Madhav Deshpande, & Mayuri Amol Deshpande. (2020). Role of Rasayan Churna in outbreak of Covid -19 as preventive and curative aspect. International Journal of Research in Pharmaceutical Sciences, 11((SPL 1), 1208–1212. Retrieved from https://ijrps.com/home/article/view/1834

Article Details

No Related Submission Found